Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane-based regimens.

Authors :: Koizumi S
Doi R
Aitake U
Lei X
Izumi T
Mori T
Shojiguchi N
Kawasaki T
Inozume T
Kishi A
Source :: The Journal of dermatology [J Dermatol] 2024 Jun; Vol. 51 (6), pp. e203-e204. Date of Electronic Publication: 2024 Jan 12.
Publication Year :: 2024

Subjects :: Humans
Skin Neoplasms drug therapy
Skin Neoplasms genetics
Skin Neoplasms pathology
Male
Aged
Female
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Treatment Failure
Antineoplastic Agents, Immunological therapeutic use
Paget Disease, Extramammary drug therapy
Paget Disease, Extramammary genetics
Paget Disease, Extramammary diagnosis
Paget Disease, Extramammary pathology
Antibodies, Monoclonal, Humanized therapeutic use
Antibodies, Monoclonal, Humanized administration & dosage
Mutation
Taxoids therapeutic use
Taxoids administration & dosage

Full Text Access

Tools